96 related articles for article (PubMed ID: 15631189)
1. [Assessment of serum levels of some angiogenic factors in healthy children].
Pałgan I; Czerwionka-Szaflarska M; Pałgan K; Szaflarska-Popławska A; Lis K; Odrowaz-Sypniewska G
Wiad Lek; 2004; 57(7-8):343-6. PubMed ID: 15631189
[TBL] [Abstract][Full Text] [Related]
2. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
4. Determination of the age-related changes of serum basic fibroblast growth factor (bFGF) level in healthy Japanese subjects.
Okamoto Y; Tanaka M; Miyahara N; Tanabe M; Gotoh Y; Fujita N; Fukui T; Masuzawa T
Clin Lab; 2009; 55(3-4):114-9. PubMed ID: 19462933
[TBL] [Abstract][Full Text] [Related]
5. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
Bremnes RM; Camps C; Sirera R
Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions.
Economidou F; Antoniou KM; Tzanakis N; Sfiridaki K; Siafakas NM; Schiza SE
Respir Med; 2008 May; 102(5):774-9. PubMed ID: 18304793
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations--preliminary report.
Przewratil P; Sitkiewicz A; Wyka K; Andrzejewska E
Pediatr Dermatol; 2009; 26(4):399-404. PubMed ID: 19689513
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of basic fibroblastic growth factor (bFGF) in children with vascular anomalies: Another insight into endothelial growth.
Przewratil P; Sitkiewicz A; Andrzejewska E
Clin Biochem; 2010 Jul; 43(10-11):863-7. PubMed ID: 20362567
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic cytokines in serum and cutaneous lesions of patients with polyarteritis nodosa.
Kikuchi K; Hoashi T; Kanazawa S; Tamaki K
J Am Acad Dermatol; 2005 Jul; 53(1):57-61. PubMed ID: 15965421
[TBL] [Abstract][Full Text] [Related]
12. Determination of age-related changes in human vascular endothelial growth factor in the serum and urine of healthy subjects.
Okamoto Y; Nagai T; Nakajo I; Seta K; Gotoh Y; Fujita N; Fukui T; Masuzawa T
Clin Lab; 2008; 54(5-6):173-7. PubMed ID: 18780663
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
15. Proangiogenic cytokines vascular-endothelial growth factor and basic fibroblst growth factor in childhood lymphadenopathy.
Mizia-Malarz A; Sobol G; Musioł K; Janowska J; Zahorska-Markiewicz B; Wos H
Pediatr Hematol Oncol; 2010 Aug; 27(5):393-404. PubMed ID: 20615068
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
17. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growth factor--the characteristics and function].
Mizia-Malarz A; Sobol G; Woś H
Przegl Lek; 2008; 65(7-8):353-7. PubMed ID: 19004235
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart.
Pagonopoulou O; Efthimiadou A; Lambropoulou M; Papadopoulos N; Nikolettos NK
In Vivo; 2008; 22(5):587-91. PubMed ID: 18853751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
